Lobbying disclosures · Lobbying report
NBIX: third_quarter 2026 lobbying report
Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally such as drug pricing and telehealth policy
Follow NBIX- Became public
- Oct 20, 2026, 2:20 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 5:07 PM EST
Why this is connected
Exact legal-name match: NEUROCRINE BIOSCIENCES INC (https://www.sec.gov/Archives/edgar/data/914475/).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/2e79db6a-4b1d-41f9-9d08-1ac90d2e16a0/","filing_uuid":"2e79db6a-4b1d-41f9-9d08-1ac90d2e16a0","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/2e79db6a-4b1d-41f9-9d08-1ac90d2e16a0/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Chelsea J. Mincheff","dt_posted":"2026-10-20T14:20:08-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th Street, NW","registrant_address_2":"11th Floor South","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":5357,"url":"https://lda.gov/api/v1/registrants/5357/","house_registrant_id":31564,"name":"BGR GOVERNMENT AFFAIRS","description":"Lobbying firm","address_1":"601 13th Street, NW","address_2":"11th Floor South","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHELSEA MINCHEFF","contact_telephone":"+1 202-661-6385","dt_updated":"2026-07-30T12:12:37.308899-04:00"},"client":{"id":106706,"url":"https://lda.gov/api/v1/clients/106706/","client_id":1007146,"name":"NEUROCRINE BIOSCIENCES, INC.","general_description":"Biotechnology company","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-03-15"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally such as drug pricing and telehealth policy","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62729,"prefix":null,"prefix_display":null,"first_name":"BRENT","nickname":null,"middle_name":"ALAN","last_name":"DEL MONTE","suffix":null,"suffix_display":null},"covered_position":"Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee","new":false},{"lobbyist":{"id":65427,"prefix":null,"prefix_display":null,"first_name":"ROBB","nickname":null,"middle_name":null,"last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":"Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes","new":false},{"lobbyist":{"id":67545,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":"Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C","new":false},{"lobbyist":{"id":143823,"prefix":"ms","prefix_display":"MS.","first_name":"REMY","nickname":null,"middle_name":"LEIGH BRIM","last_name":"MASON","suffix":null,"suffix_display":null},"covered_position":"Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz","new":false},{"lobbyist":{"id":73551,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"FARMER","suffix":null,"suffix_display":null},"covered_position":"Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space","new":false},{"lobbyist":{"id":23860,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"WOOD","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff to HHS Secretary; Intern to Rep. Scott Klug","new":false},{"lobbyist":{"id":121840,"prefix":null,"prefix_display":null,"first_name":"JOEL","nickname":null,"middle_name":"D.","last_name":"BAILEY","suffix":null,"suffix_display":null},"covered_position":"COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall","new":false},{"lobbyist":{"id":146083,"prefix":null,"prefix_display":null,"first_name":"RAGHAV","nickname":null,"middle_name":null,"last_name":"AGGARWAL","suffix":null,"suffix_display":null},"covered_position":"Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior","new":false},{"lobbyist":{"id":151142,"prefix":"mr","prefix_display":"MR.","first_name":"MARVIN","nickname":null,"middle_name":"BENITO","last_name":"FIGUEROA","suffix":null,"suffix_display":null},"covered_position":"COS, Sen. Laphonza Butler; Dir. of Off. of Inter. Affairs and Ext. Affairs, HHS; Sen. Policy Adv., Leg. Asst., Leg. Aide, Leg. Corr., Sec. Edu. Grad. Fellow, Sen. Mark Warner; Intern, White House","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in NBIX
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Sold (partial) Neurocrine Biosciences NBIX
$1K–$15K · Traded Jun 17, 2025 · disclosed Aug 13, 2025 · Spouse · filed 57 days later
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Bought Neurocrine Biosciences NBIX
$1K–$15K · Traded Jun 11, 2025 · disclosed Aug 13, 2025 · Spouse · filed 63 days later
- Jun 22, 2023$15K–$50K
Rep. Michael T. McCaul (R-TX-10)
Sold Neurocrine Biosciences NBIX
$15K–$50K · Traded May 2, 2023 · disclosed Jun 22, 2023 · filed 51 days later
- Jun 22, 2023$15K–$50K
Rep. Michael T. McCaul (R-TX-10)
Sold Neurocrine Biosciences NBIX
$15K–$50K · Traded May 2, 2023 · disclosed Jun 22, 2023 · Spouse · filed 51 days later
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.